Biofabrication of 3D printed hydroxyapatite composite scaffolds for bone regeneration

Biofabrication has been adapted in engineering patient-specific biosynthetic grafts for bone regeneration. Herein, we developed a three-dimensional (3D) high-resolution, room-temperature printing approach to fabricate osteoconductive scaffolds using calcium phosphate cement (CPC). The non-aqueous CPC bioinks were composed of tetracalcium phosphate, dicalcium phosphate anhydrous, and Polyvinyl butyral (PVB) dissolved in either ethanol (EtOH) or tetrahydrofuran (THF). They were printed in an aqueous sodium phosphate bath, which performs as a hardening accelerator for hydroxyapatite formation and as a retainer for 3D microstructure. The PVB solvents, EtOH or THF, affected differently the slurry rheological properties, scaffold microstructure, mechanical properties, and osteoconductivity. Our proposed approach overcomes limitations of conventional fabrication methods, which require high-temperature (>50 degrees C), low-resolution (>400 mu m) printing with an inadequate amount of large ceramic particles (>35 mu m). This proof-of-concept study opens venues in engineering high-resolution, implantable, and osteoconductive scaffolds with predetermined properties for bone regeneration.

Automated summary

Biofabrication has been utilized to engineer patient-specific biosynthetic grafts for bone regeneration, with a new 3D printing approach developed in this study using calcium phosphate cement (CPC) and non-aqueous CPC bioinks. The choice of PVB solvents, EtOH or THF, was found to affect the rheological properties, microstructure, mechanical properties, and osteoconductivity of the scaffolds. This novel method opens up possibilities for engineering high-resolution, implantable, and osteoconductive scaffolds with predetermined properties for bone regeneration.